On October 8, NCI rose 3.17% in regular trading, trading at HK$45.58 per share, with turnover of HK$64.73 million.

The stock's advance came amid disclosure that JPMorgan Chase & Co. reduced its long position in NCI H-shares below the 5% threshold through an off-exchange transaction on September 29, selling 8.30 million shares at an average price of HK$45.2163 for approximately HK$375 million, lowering its long position from 5.02% to 4.21% while its short position rose to 1.68%.

Broader sector context remains supportive, as analysts note that the insurance industry is entering a phase where improving interest spread expectations and profit realization may coincide, offering meaningful valuation elasticity for insurance stocks amid ongoing liability cost reforms and dynamic pricing mechanisms.

NCI operates as a life and health insurance provider in China, offering traditional life, health and accident insurance, participating insurance products with direct dividend features, and universal life products through three business segments, alongside health and wealth management services.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)